Pay in 4 interest-free payments of $5.04 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Mechanism of Action: Triple Receptor Agonist Retatrutide is a synthetic peptide that activates three key metabolic receptors: GLP-1 (Glucagon-Like Peptide-1) Enhances insulin secretion, suppresses appetite, delays gastric emptying GIP (Glucose-Dependent Insulinotropic Polypeptide) Boosts insulin response, improves insulin sensitivity, may support lipid metabolism Glucagon Receptor (GCGR) Elevates energy expenditure, promotes fat oxidation, and may reduce liver fat This triple agonist profile delivers synergistic effects on glycemic control, fat loss, and metabolic health, making Retatrutide the most advanced incretin-based peptide in development
Research applications include: Investigation of combined peptide signalling pathways Studies on structural effects of copper-peptide complexes Analysis of cellular regulation through peptide fragments Modelling of synergistic peptide interactions The blend is intended exclusively for fundamental research on peptide-driven biological processes
The Math The formula for any vial size and any amount of water: Concentration = Peptide Amount (mcg) / Water Added (mL) For injection volume: Units to inject = Desired Dose (mcg) / Concentration (mcg/mL) x 100 Example: 5,000mcg vial + 2mL water = 2,500mcg/mL
The best person to answer your questions about the recommended treatment(s) and anticipated recovery time is your healthcare professional
Most patients starting with normal b12 levels and no significant risk factors do not require supplementation
US$ 29.33
US$ 23.05
US$ 22.31
US$ 25.02
